FDA grants orphan drug designation for novel gene therapy as treatment of Fanconi anemia type A May 5, 2016 No Comments
Merck & Co. discloses hypoxia-inducible factor prolyl hydroxylase inhibitors April 26, 2016 No Comments
RSS